Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial

Amit Kaura1,2, Laszlo Sztriha3, Fong Kum Chan3

  • 1King's College London NHS Foundation Trust, King's College Hospital, Denmark Hill, London, SE5 9RS, UK. amit.kaura@nhs.net.

Insights

A 14-day ECG patch detected significantly more cases of paroxysmal atrial fibrillation (PAF) than Holter monitors after stroke or TIA. This prolonged monitoring is more effective and cost-effective for preventing future strokes.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • Cardioembolism from paroxysmal atrial fibrillation (PAF) is a preventable cause of transient ischemic attack (TIA) or ischemic stroke.
  • Short-duration Holter monitoring may miss a significant proportion of PAF events due to their transient nature.

Purpose of the Study:

  • To compare the diagnostic yield of a 14-day ECG monitoring patch versus short-duration Holter monitoring for detecting PAF in patients who have experienced a TIA or ischemic stroke.
  • To assess the cost-effectiveness of patch-based monitoring for preventing recurrent strokes.

Main Methods:

  • An open-label randomized controlled trial comparing a 14-day ECG monitoring patch (Zio® Patch) with short-duration Holter monitoring.
  • Primary outcome: detection of ECG-documented PAF (≥30 seconds) within 90 days.
  • Included a budget impact analysis from a healthcare perspective.

Main Results:

  • The 14-day patch detected PAF in 16.3% of patients, compared to 2.1% with Holter monitoring (Odds Ratio 8.9, P=0.026).
  • Successful monitor placement was high in both groups (76.8% patch vs. 78.3% Holter).
  • The patch-based approach was projected to avoid 10.8 strokes annually and save over £113,000 in direct medical costs.

Conclusions:

  • Early, prolonged, patch-based monitoring is superior to short-duration Holter monitoring for detecting PAF after stroke or TIA.
  • Patch-based monitoring is likely cost-effective for preventing recurrent strokes.
  • The Zio® Patch demonstrated higher diagnostic yield and potential for significant healthcare cost savings.
Abstract

Related Concept Videos

Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
3.2K
Cardiac Output and Stroke Volume01:11

Cardiac Output and Stroke Volume

Cardiac output (CO) is an integral aspect of human physiology, reflecting the heart's efficiency and responsiveness to the body's needs. It represents the volume of blood that the left or right ventricle ejects into the aorta or pulmonary trunk each minute. The CO is calculated by multiplying the heart rate (HR)—the number of heartbeats per minute—by the stroke volume (SV)—the amount of blood pumped out with each heartbeat.
In an average resting adult male, the typical cardiac...
4.5K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
399
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
4.7K